相关实验视频

Updated: Jun 13, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

工程PEG10组装了内源性病毒样颗粒与基因编码的新抗原,用于癌症疫苗接种

Ruijing Tang^1,2,3, Luobin Guo^1,2,3, Tingyu Wei^1,2,3

¹The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.

|September 13, 2024

概括

一种新的工程瘤疫苗 (ePAC) 有效地将新抗原和辅助剂传递给树突细胞,增强癌症免疫疗法. 这种方法显示出在抗瘤治疗中临床翻译的巨大潜力.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

癌症免疫疗法在联合向抗原呈现细胞提供新抗原和辅助剂方面面临挑战.
类似病毒的粒子 (VLP) 可以输送治疗物质,但在体内向和抗体中和能力较弱.
PEG10是一种来自哺乳动物的囊蛋白,为自组装内源性VLP (eVLP) 提供了一种新型载体,具有高负载和转化效率.

研究的目的:

开发一种工程瘤疫苗 (ePAC),以有效地在体内输送新抗原和辅助剂.
利用基于PEG10的eVLP来增强对抗原呈现细胞的向,特别是树突细胞 (DC).
在临床前癌症模型中评估ePAC与抗TIM-3疗法结合的治疗潜力.

主要方法:

设计了一种使用PEG10形成自组装eVLP的新型蛋白质载体.
通过将新抗原包装成eVLPs并使用CpG-ODN作为DCs的辅助和准部分来设计ePAC.
评估ePAC向DCs的能力,促进DC成熟,诱导新抗原特异性T细胞,以及其在小鼠模型中的抗瘤疗效.

主要成果:

基于PEG10的eVLP显示了高的蛋白质加载和转化效率.
ePAC有效地向并将新抗原传递给DC,促进DC成熟并诱导新抗原特异性T细胞.
与抗TIM-3疗法结合的ePAC在正型肝癌和人性化小鼠瘤模型中显示出显著的抗瘤疗效.

结论:

ePAC代表了一个有前途的癌症疫苗平台,可以有效地提供新抗原和辅助剂.
基于PEG10的eVLP系统为癌症疫苗开发提供了一种安全有效的方法.
ePAC在抗瘤治疗中显示出临床转化显著潜力.

关键词:

在CpG-ODNN中使用.在PEG10的基础上,PEG10 癌症生物学癌症生物学这里是鼠标鼠标鼠标鼠标鼠标鼠标.新抗原是一种新抗原.

更多相关视频

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.